Showing 31 - 40 of 55,456
Persistent link: https://www.econbiz.de/10000909588
Persistent link: https://www.econbiz.de/10009300478
In many countries, social security insures firms against their workers' sickness absences. The insurance may create a moral hazard for firms, leading to inefficient monitoring of absences or to an underinvestment in the prevention of absences. We exploit an administrative threshold in the...
Persistent link: https://www.econbiz.de/10013050299
Persistent link: https://www.econbiz.de/10012794254
In this paper we test the 'red herring' hypothesis for expenditures on long-term care. The main contribution of this paper is that we assess the 'red herring' hypothesis using an aggregated measure that allows us to control for entering the final period of life on the individual level. In...
Persistent link: https://www.econbiz.de/10009349762
expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … utilization in Sweden, so the cost per life-year gained from the introduction of new drugs was quite low …
Persistent link: https://www.econbiz.de/10013315886
This paper reviews the strengths and weaknesses of the Swedish healthcare system and the challenges that it will face in the future. It discusses ways to improve access to primary care, including different methods for paying GPs, whether access is less equitable than in other countries and the...
Persistent link: https://www.econbiz.de/10012444997
, Korea, Sweden and Switzerland. In particular, it reviews the methods of financing population health investments and levels …
Persistent link: https://www.econbiz.de/10012446196
Persistent link: https://www.econbiz.de/10011654699
Persistent link: https://www.econbiz.de/10012061272